Yi Liu1, Yuxia Ma2, Yunfeng Liu3, Wenhao Wang3, Feifei Liu4. 1. Cangzhou Prison, No.47 Hexi North Street, Cangzhou, 061001, Hebei, China. 2. Department of Internal Medicine, Cangzhou Central Hospital, No.16 Xinhua West Road, Cangzhou, 061001, Hebei, China. DrMayuxia@foxmail.com. 3. Department of Internal Medicine, Cangzhou Central Hospital, No.16 Xinhua West Road, Cangzhou, 061001, Hebei, China. 4. Department of Internal Medicine, Cangzhou People's Hospital, Cangzhou, 061000, Hebei, China.
Abstract
BACKGROUND: Due to the improved clinical management of aging population and the consequently declined mortality among patients with critical illnesses, the number of survivors from intensive care units (ICUs) keeps rising. Studies to examine the association of cognitive impairment analgesic and sedation strategies would be beneficial to improve the quality of life of ICU survivors. METHODS: A prospective clinical trial was designed to compare the effects of two drugs, propofol, and dexmedetomidine, on short-term cognitive impairment after sedation in elderly ICU survivors by evaluating the extent of independence limited by the dementia-related activities of daily livings (ADLs). The plasma concentrations of brain injury biomarkers including S100β and neuron-specific enolase (NSE) were determined using an enzyme immunoassay. There were 136 patients allocated into both thedexmedetomidine group and the propofol group, respectively, with matched demographic characteristics. RESULTS: The dementia scale of the patients in the dexmedetomidine group was significantly higher than the propofol group at weeks 1-4. Moreover, the changes in S100β and NSE concentrations in the dexmedetomidine group were significantly more pronounced than the propofol group. ICU patients who received dexmedetomidine intervention showed higher cognitive impairment than patients who received propofol, and this protective effect of propofol was not associated with the levels of brain injury markers S100β and NSE. CONCLUSION: Our study compared the effects of commonly used medications on short-term cognitive impairment in elderly ICU patients, which would aid the selection of sedation plan for the benefit of ICU patients.
RCT Entities:
BACKGROUND: Due to the improved clinical management of aging population and the consequently declined mortality among patients with critical illnesses, the number of survivors from intensive care units (ICUs) keeps rising. Studies to examine the association of cognitive impairment analgesic and sedation strategies would be beneficial to improve the quality of life of ICU survivors. METHODS: A prospective clinical trial was designed to compare the effects of two drugs, propofol, and dexmedetomidine, on short-term cognitive impairment after sedation in elderly ICU survivors by evaluating the extent of independence limited by the dementia-related activities of daily livings (ADLs). The plasma concentrations of brain injury biomarkers including S100β and neuron-specific enolase (NSE) were determined using an enzyme immunoassay. There were 136 patients allocated into both the dexmedetomidine group and the propofol group, respectively, with matched demographic characteristics. RESULTS: The dementia scale of the patients in the dexmedetomidine group was significantly higher than the propofol group at weeks 1-4. Moreover, the changes in S100β and NSE concentrations in the dexmedetomidine group were significantly more pronounced than the propofol group. ICU patients who received dexmedetomidine intervention showed higher cognitive impairment than patients who received propofol, and this protective effect of propofol was not associated with the levels of brain injury markers S100β and NSE. CONCLUSION: Our study compared the effects of commonly used medications on short-term cognitive impairment in elderly ICU patients, which would aid the selection of sedation plan for the benefit of ICU patients.
Entities:
Keywords:
Activities of daily living (ADLs); Dementia; Dexmedetomidine; Intensive care unit (ICU); Propofol
Authors: Shannon S Carson; Christopher E Cox; George M Holmes; Ann Howard; Timothy S Carey Journal: J Intensive Care Med Date: 2006 May-Jun Impact factor: 3.510
Authors: James C Jackson; Robert P Hart; Sharon M Gordon; Ayumi Shintani; Brenda Truman; Lisa May; E Wesley Ely Journal: Crit Care Med Date: 2003-04 Impact factor: 7.598
Authors: Margaret S Herridge; Angela M Cheung; Catherine M Tansey; Andrea Matte-Martyn; Natalia Diaz-Granados; Fatma Al-Saidi; Andrew B Cooper; Cameron B Guest; C David Mazer; Sangeeta Mehta; Thomas E Stewart; Aiala Barr; Deborah Cook; Arthur S Slutsky Journal: N Engl J Med Date: 2003-02-20 Impact factor: 91.245
Authors: Annemiek E Wolters; Arjen J C Slooter; Arendina W van der Kooi; Diederik van Dijk Journal: Intensive Care Med Date: 2013-01-18 Impact factor: 17.440
Authors: Patrick L Purdon; Eric T Pierce; Eran A Mukamel; Michael J Prerau; John L Walsh; Kin Foon K Wong; Andres F Salazar-Gomez; Priscilla G Harrell; Aaron L Sampson; Aylin Cimenser; ShiNung Ching; Nancy J Kopell; Casie Tavares-Stoeckel; Kathleen Habeeb; Rebecca Merhar; Emery N Brown Journal: Proc Natl Acad Sci U S A Date: 2013-03-04 Impact factor: 11.205
Authors: Ramona O Hopkins; Lindell K Weaver; Dave Collingridge; R Bruce Parkinson; Karen J Chan; James F Orme Journal: Am J Respir Crit Care Med Date: 2004-11-12 Impact factor: 21.405